These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27296759)

  • 1. Dry Eye Disease: Present Challenges in the Management and Future Trends.
    Al-Saedi Z; Zimmerman A; Bachu RD; Dey S; Shah Z; Baugh R; Boddu SH
    Curr Pharm Des; 2016; 22(28):4470-90. PubMed ID: 27296759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding dry eye disease: a managed care perspective.
    Fiscella RG
    Am J Manag Care; 2011 Dec; 17 Suppl 16():S432-9. PubMed ID: 22435675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quintessence of currently approved and upcoming treatments for dry eye disease.
    Patil S; Sawale G; Ghuge S; Sathaye S
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; ():. PubMed ID: 39215848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFOS DEWS II Tear Film Report.
    Willcox MDP; Argüeso P; Georgiev GA; Holopainen JM; Laurie GW; Millar TJ; Papas EB; Rolland JP; Schmidt TA; Stahl U; Suarez T; Subbaraman LN; Uçakhan OÖ; Jones L
    Ocul Surf; 2017 Jul; 15(3):366-403. PubMed ID: 28736338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomicroscopy of the tear film: aqueous and lipid tear substitutes in the normal and abnormal eye.
    Carrington S; Bedford PG; Guillon JP; Carlile JL; Woodward EG
    Vet Rec; 1988 Sep; 123(13):329-35. PubMed ID: 3195015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models.
    Choi KE; Song JS; Kang B; Eom Y; Kim HM
    Curr Eye Res; 2017 May; 42(5):666-671. PubMed ID: 27791390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TFOS DEWS II Diagnostic Methodology report.
    Wolffsohn JS; Arita R; Chalmers R; Djalilian A; Dogru M; Dumbleton K; Gupta PK; Karpecki P; Lazreg S; Pult H; Sullivan BD; Tomlinson A; Tong L; Villani E; Yoon KC; Jones L; Craig JP
    Ocul Surf; 2017 Jul; 15(3):539-574. PubMed ID: 28736342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment.
    Chao W; Belmonte C; Benitez Del Castillo JM; Bron AJ; Dua HS; Nichols KK; Novack GD; Schrader S; Willcox MD; Wolffsohn JS; Sullivan DA
    Ocul Surf; 2016 Apr; 14(2):264-316. PubMed ID: 26774910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of dry eye.
    Drug Ther Bull; 2016 Jan; 54(1):9-12. PubMed ID: 26763598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
    Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
    Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy].
    Safonova TN; Gladkova OV; Boev VI; Fedorov AA
    Vestn Oftalmol; 2016; 132(5):39-48. PubMed ID: 27911424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [If Artificial Tears Aren't Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti-Inflammatory Therapy of Dry Eye Disease].
    Pleyer U; Geerling G; Schrader S; Jacobi C; Kimmich F; Messmer E
    Klin Monbl Augenheilkd; 2020 May; 237(5):655-668. PubMed ID: 32434249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva.
    Chen W; Zhao K; Li X; Yoshitomi T
    Cornea; 2007 Oct; 26(9):1101-6. PubMed ID: 17893543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in pharmaceutical treatment of dry eye disease: A review.
    Mohamed HB; Abd El-Hamid BN; Fathalla D; Fouad EA
    Eur J Pharm Sci; 2022 Aug; 175():106206. PubMed ID: 35568107
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.